The annual StemCONN conference, held April 27 in New Haven, made clear that Connecticut’s commitment to stem cell research has helped the state become a national leader in this burgeoning area of research and commercial development.
Wesleyan is one of the founders of the StemCONN conference, along with Yale and the University of Connecticut. This year marks the 6th StemCONN conference, an event that brings together more than 500 individuals from academic institutions, bioscience industry, and government.
“Stem cell research continues to be an exciting and fast-paced field with new discoveries fueling prospects for new therapies based on regenerative medicine for a range of debilitating medical conditions, and Connecticut is at the leading edge of this field,” said Janice Naegele, professor of biology and one of the symposium’s organizers. “A major emphasis of StemConn’s mission is education, and this year’s conference attendees included undergraduate trainees, graduate students, and postdoctoral fellows. Special interactive sessions over lunch provided a fabulous small group format for undergraduate and graduate students to ask questions and discuss career paths with our invited speakers. This is a one of a kind opportunity for many of our trainees.”
Connecticut passed ground-breaking legislation in 2005, becoming the first state to fully approve funding for stem cell research. The 12-year, $100-million per year initiative has enabled the state to compete successfully for scientific talent in the field and has helped to establish a growing bioscience corridor in the Hartford-New Haven area.